Trump’s 200% generic tariff threat would imperil Americans: Indian pharma
U.S. President Donald Trump. File | Photo Credit: Reuters U.S. President Donald Trump has given generic pharmaceutical companies a two-year window to establish manufacturing facilities in the United States, warning that products imported after August 2028 could face tariffs of up to 200%. The announcement, made on Wednesday (July 22, 2026) through a social media…
Read More “Trump’s 200% generic tariff threat would imperil Americans: Indian pharma” »